Verisian
London
About Verisian
Accelerate drug time to market through real study traceability and unparalleled trial integrity
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $5.6M
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: verisian.com
- Phone: [email protected]
Industries & Categories
Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/verisian-36388 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.